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Abstract
Background: The aim of this study was to compare pre-arrest and post-resuscitation organ perfusion
values and to investigate whether, during the post-resuscitation phase, administration of the
angiotensin II antagonist telmisartan (TELM) 10 min after restoration of spontaneous circulation
(ROSC) could improve organ flow in comparison to placebo.
Results: Five minutes after ROSC in the TELM group, blood flow in the cortex and myocardium
increased to 583% (P < 0.05) and 137% (not significant), respectively, whereas blood flow of the
colon, stomach and pancreas decreased to 50% (P < 0.05), 28% (P < 0.05) and 19% (P < 0.05) of
pre-arrest values, respectively. At 90 min after ROSC, pre-arrest perfusion values both in non-
splanchnic and splanchnic organs were achieved. At no point in time were there significant differences
between the two groups with respect to organ blood flow or speed of recovery of organ perfusion.
Conclusions: During the post-resuscitation phase, organ blood flow is characterized by the
coincidence of increased cerebral and myocardial blood flow and decreased intestinal blood flow.
Administration of TELM 10 min after ROSC did not improve the recovery of organ perfusion.
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Introduction
In an effort to improve the dismal outcome of cardiac arrest,
a variety of vasopressor agents have been investigated in
animal models and in humans [1–3]. In particular, in a por-
cine model of ventricular fibrillation, administration of vaso-
pressin led to a significantly higher coronary perfusion
pressure and myocardial blood flow than high dose epine-
phrine [3]. Vasopressin, however, is reported to be a potent
splanchnic vasoconstrictor which leads to a disproportion-
ate reduction in mesenteric blood flow [4,5]. In addition,
activation of the renin-angiotensin system has been shown
to be part of the neuroendocrine response to cardiac arrest
[6,7] or severe systemic hypotension [4,8], and angiotensin
II (ANG II) mediates highly selective and potent splanchnic
vasoconstriction [4,8,9]. During hemorrhagic or cardio-
genic shock, blockade of the renin-angiotensin axis has
been shown to abolish selective splanchnic vasoconstric-
tion [10–12]. However, blockade of the renin-angiotensin
axis during the immediate post-resuscitation phase has not
yet been evaluated. The purpose of this study was to com-
pare splanchnic and non-splanchnic organ perfusion pre-
arrest to post-resuscitation values after vasopressin admin-
istration in a porcine model of cardiopulmonary resuscita-
tion (CPR) and to investigate whether, during the
immediate post-resuscitation phase, administration of the
ANG II antagonist telmisartan (TELM) could improve organ
blood flow in comparison with saline.
Materials and methods
Animal preparation
This investigation was approved by the animal investigation
committee of the state of Baden-Württemberg. Care and
handling of the animals was in accordance with the United
States National Institutes of Health Guidelines.
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kg were fasted for 10 h before surgery, but had free access
to water. After premedication with azaperone (4 mg/kg im)
and atropine (0.1 mg/kg) 30 min before induction of sur-
gery, anesthesia was induced by injecting sodium pento-
barbital (15 mg/kg) into an ear vein, followed by continuous
infusion of pentothal at a dosage of 0.5 mg/kg per min.
Analgesia was achieved with a bolus dose of buprenor-
phine (0.02 mg/kg). The animals were intubated endotra-
cheally and ventilation was performed using a Servo
ventilator (Servo, Siemens, Erlangen, Germany) with 65%
nitrous oxide in oxygen at 20 breaths/min with the tidal vol-
ume set to maintain normocapnia.
A standard II electrocardiogram was recorded using three
subcutaneous electrodes. Three 7-Fr catheters were
inserted via femoral cutdowns in the descending aorta for
monitoring of blood pressure or withdrawal of blood sam-
ples. A 7-Fr catheter was placed under digital control via
the right external jugular vein into the hepatic vein.
The correct position of this catheter was confirmed both by
hepatic venous oxygen saturation control and by autopsy at
the end of the experiment. Two separate 5-Fr catheters in
the right atrium and in the inferior vena cava were used for
drug administration. A 7-Fr pigtail catheter was advanced
under pressure control via a femoral cutdown into the left
ventricle in order to inject radiolabeled microspheres for the
measurement of organ perfusion. A 7.5-Fr pulmonary artery
catheter (Edwards Critical-Care Division, Irvine, CA, USA)
was placed via the left external jugular vein into the pulmo-
nary artery. Body temperature (blood temperature) was
recorded from the thermistor of the pulmonary artery cath-
eter and maintained between 37.5°C and 38.5°C using a
heating pad. During the preparation and post-resuscitation
phase, the animals received 6 ml/kg per h Ringer's solution
and a total of 500 ml 3% gelatine solution to replace blood
loss due to surgical preparation. In addition, during the
preparation phase, right atrial and pulmonary arterial pres-
sures were used to guide volume replacement in order to
maintain comparable left ventricular and right ventricular fill-
ing pressures before induction of cardiac arrest.
Experimental protocol
Before the induction of cardiocirculatory arrest, hemody-
namic parameters, and arterial, mixed venous and hepatic
venous blood gases, as well as vital organ perfusion were
measured. Ventricular fibrillation was induced with a 50 Hz
alternating current administered to the thorax via two sub-
cutaneous needle electrodes. Ventilation was stopped at
this point. After 4 min of cardiac arrest, closed-chest CPR
was performed at a rate of 80/min. The compression force
was applied to the animal's midsternum, whereas relaxation
(decompression) was allowed to occur passively. The
depth of compression was approximately 25% of the ante-
rior-posterior thorax diameter and the duration of compres-
sion was approximately 50% of the total cycle time. On
initiation of cardiac massage, ventilation was resumed with
100% oxygen, a respiratory rate of 20 breaths/min and at a
tidal volume that had been determined as resulting in nor-
mocapnia before arrest.
In a previous animal study, vasopressin was shown to be
superior to epinephrine with respect to the percentage of
successful resuscitations [3]. After 3 min of CPR, therefore,
all animals received 0.4 U/kg vasopressin (Pitressin, Parke-
Davis GmbH, Freiburg, Germany) given via a central
venous catheter over a period of 5 s. Ninety seconds after
vasopressor administration, we attempted to restore spon-
taneous circulation with direct current shocks using a
LIFEPAK 6 defibrillator (Physiocontrol Corporation, Red-
mont, Washington, USA). Three countershocks were ini-
tially administered at an energy setting of 3 J/kg. In the case
of persisting ventricular fibrillation, the same drug was
administered at the same dose as initially given and CPR
was resumed for a further 90 s with three subsequently
delivered countershocks at an energy setting of 5 J/kg. The
same protocol (without defibrillation) was used if asystole
or pulseless electrical activity developed. Restoration of
spontaneous circulation (ROSC) was defined as coordi-
nated electrical activity and a systolic blood pressure  > 90
mmHg for at least 5 min. At the beginning of the post-resus-
citation phase, anesthesia was resumed with a continuous
infusion of 0.2 mg/kg per min pentobarbital and a further
0.01 mg/kg bolus of buprenorphine.
Ten minutes after ROSC, the animals were randomly allo-
cated to receive either a 1 mg/kg bolus of the ANG II antag-
onist TELM (Karl Thomae GmbH, Biberach, Germany)
diluted in 10 ml physiologic saline, followed by a continu-
ous infusion of TELM at a dosage of 30 mg/kg per h (TELM
group), or placebo (control group). Telmisartan is a selec-
tive antagonist of the ANG II receptor subtype 1 and has no
agonistic properties [13,14]. Telmisartan interacts neither
with ANG II receptor subtype 2 nor with other receptor sys-
tems. In previous experiments, the dosage chosen has
been found to perform insurmountable antagonism of car-
diovascular effects induced by ANG II [13].
Measurements
Heart rate was recorded from the signal of a standard elec-
trocardiograph. Pressures were continuously recorded
from the aorta, right atrium and pulmonary artery using a
multi-channel recorder (ADAS, Thomae GmbH, Germany).
These pressures were evaluated pre-arrest and at 5, 30, 90
and 240 min after ROSC (ie pre-arrest, 5 min before, and
20, 80 and 230 min after drug administration). Using a
cardiac output computer (Baxter Edwards Critical Care,
Irvine, CA, USA), cardiac output was evaluated in triplicate
Available online http://ccforum.com/content/2/2/49by the thermodilution technique pre-arrest, and at 5, 30, 90
and 240 min after ROSC.
Arterial, mixed venous and hepatic venous blood gases,
and hemoglobin content were measured with a blood gas
analyzer (Radiometer, ABL 330, Copenhagen, Denmark).
Using radiolabeled microspheres [15], organ blood flow
was measured pre-arrest and at 5, 30, 90 and 240 min
after ROSC. Microspheres (New England Nuclear,
Dreieich, Germany; mean diameter 15 ± 1.5 mm) were
labeled with 141cerium, 95niobium, 103ruthenium,
46scandium and 85strontium. Each microsphere vial was
placed into a water bath and subjected to ultrasonic vibra-
tion for 1 min before injection. Approximately 5 × 105
microspheres were diluted in 10 ml saline and then imme-
diately injected into the left ventricle. Using an automatic
withdrawal pump (Braun, Melsungen, Germany), blood
was continuously withdrawn from the catheter lying in the
descending aorta at a rate of 6 ml/min (known `organ'
blood flow) for 2 min. At the end of the experiment, aliquots
of left ventricular free wall, cerebrum, liver, spleen, stomach,
pancreas, jejunum, colon, kidney and adrenal gland were
removed. The radioactivity of the blood collected (count of
the reference `organ' with known flow) was measured with
a gamma scintillation spectrometer (LB 5300, Berthold,
Wildbad, Germany) as was the radioactivity in the homog-
enized tissue samples (count of the organs with unknown
flow). The flow of any organ (unknown organ flow) could be
calculated using the following relationship:
Unknown organ flow/count in the organ with unknown flow
= known `organ' flow/count in the `organ' with known flow.
Hepatic blood flow was evaluated by infusing indocyanine
green (ICG; Cardio Green, Hynson, Westcott and Dun-
ning, Baltimore, MD, USA) into a peripheral vein [16,17].
This method is based on the Fick principle which means
that under constant flow conditions, the blood volume mov-
ing through an organ (eg the liver) can be calculated by
determining the amount of indicator extracted over that
time and the concentration difference of the indicator enter-
ing (arterial) and leaving (hepatic venous) that organ. In the
case of ICG which is exclusively removed by the liver, the
intravenous infusion rate equals the rate of hepatic removal.
The ICG was infused continuously for at least 90 min
before sampling to achieve steady state conditions of ICG
concentration. Pre-arrest and at 30, 90 and 240 min after
ROSC, three blood samples at 3-min intervals were taken
simultaneously from the artery and hepatic vein for ICG
measurement. Immediately after centrifugation, the plasma
was frozen at -76°C until the time of analysis. Using spec-
trophotometric detection, the absorbance of the samples
was read at 800 nm and the concentration of ICG was cal-
culated using standard curves constructed from control
samples.
Statistical analysis
Data are given as mean ± SEM. The Friedmann test fol-
lowed by the Wilcoxon matched pairs test was used to
compare pre-arrest values with those 5 min and 240 min
after ROSC within one group. The Mann-Whitney U test
(two-tailed) with Bonferroni correction for multiple compar-
ison was used to determine differences between the TELM
group and the control group. P < 0.05 was considered sta-
tistically significant.
Results
There were no significant differences in the total number of
defibrillations per animal or the total dose of vasopressin
between the TELM and control group.
Cardiac index, mean arterial pressure, and cerebral and
myocardial blood flow pre-arrest and during the post-resus-
citation phase are shown in Table 1. In both groups, car-
diac index and mean arterial pressure were significantly
lower, and cerebral blood flow was significantly higher 5
min after ROSC, in comparison to pre-arrest values. At 240
min after ROSC, cerebral blood flow was significantly
higher when compared to pre-arrest values in both groups.
In contrast, at the same point in time, cardiac index was sig-
nificantly lower in comparison to pre-arrest values only in
the control group. At no point in time was there any signifi-
cant difference between the two groups.
Splanchnic organ blood flows pre-arrest and during the
post-resuscitation phase before and after drug administra-
tion are shown in Table 2. Five minutes after ROSC, organ
blood flow of the adrenal gland was significantly higher
than pre-arrest in both groups. At the same point in time,
organ blood flow of the liver, spleen, stomach, pancreas,
jejunum and colon, was significantly lower than pre-arrest.
In both groups, splanchnic organ blood flow normalized to
pre-arrest values at 90 min after ROSC, and at 240 min
after ROSC, organ blood flow of the liver, pancreas, jeju-
num, colon, kidney and adrenal gland (only in the TELM
group) significantly exceeded pre-arrest values. At no point
in time were there relevant differences between the groups
with respect to organ perfusion.
Hepatic plasma flow and hepatic blood flow pre-arrest and
during the post-resuscitation phase are shown in Table 3.
In both groups, hepatic plasma flow and hepatic blood flow
achieved pre-arrest values at 90 min after ROSC, and at
240 min after ROSC both parameters were significantly
higher in comparison to pre-arrest values. At no point of
observation was there a relevant difference between
groups with respect to hepatic plasma or blood flow.Page 3 of 7
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ing the post-resuscitation phase are shown in Tables 4 and
5. At no point of observation was there any significant dif-
ference between the groups with respect to arterial or
hepatic venous blood gases. By analogy, we found no rele-
vant differences between the two groups with respect to
hemoglobin concentrations or mixed venous blood gases
(data not presented).
Discussion
This study was designed to compare pre-arrest and post-
resuscitation splanchnic and non-splanchnic organ blood
flow after vasopressin administration in a pig model of CPR,
and to investigate whether, during the post-resuscitation
phase, administration of an ANG II antagonist could
improve splanchnic and non-splanchnic perfusion in com-
parison to saline. Results from our study demonstrate that
5 min after ROSC regional organ blood flow of the brain,
heart and adrenal gland was increased, whereas cardiac
index and splanchnic organ blood flow were decreased.
During the post-resuscitation phase, administration of an
ANG II antagonist did not change cardiac index and mean
arterial pressure when compared to saline. In addition, no
Table 1
Hemodynamic variables, and myocardial and cerebral blood flow (mean ± SEM) pre-arrest, and during the post-resuscitation phase before 
and after drug administration
Variable Group Pre-arrest Post-resuscitation phase Friedmann
5 min 30 min 90 min 240 min
MAP TELM 114 ± 4 91 ± 7* 84 ± 3 91 ± 3 90 ± 2* P < 0.01
(mmHg) Control 122 ± 11 93 ± 12* 91 ± 4 93 ± 4 92 ± 4* P < 0.05
CI TELM 115 ± 6 66 ± 7* 77 ± 7 98 ± 7 108 ± 5 P < 0.001
(ml/min/kg) Control 129 ± 9 72 ± 7* 77 ± 4 114 ± 14 102 ± 5* P < 0.001
LVMBF TELM 1.9 ± 0.2 2.6 ± 0.4 1.3 ± 0.1 2.1 ± 0.4 2.3 ± 0.5 P < 0.05
(ml/min/g) Control 2.1 ± 0.3 2.3 ± 0.3 1.4 ± 0.1 2.4 ± 0.3 2.6 ± 0.5 ns
Cortex TELM 0.36 ± 0.02 2.10 ± 0.36* 0.29 ± 0.02 0.32 ± 0.03 0.57 ± 0.14* P < 0.0001
(ml/min/g) Control 0.38 ± 0.03 2.27 ± 0.31* 0.36 ± 0.02 0.44 ± 0.07 0.57 ± 0.05* P < 0.001
CI = cardiac index; LVMBF = left ventricular myocardial blood flow; MAP = mean arterial pressure; ns = not significant; TELM = angiotensin II 
antagonist telmisartan. *P < 0.05 vs pre-arrest values by Wilcoxon matched pairs test.
Table 2
Splanchnic organ blood flow (mean ± SEM) pre-arrest and during the post-resuscitation phase before and after drug administration
Group Pre-arrest Post-resuscitation phase Friedmann
5 min 30 min 90 min 240 min
Liver TELM 0.79 ± 0.14 0.63 ± 0.13* 0.78 ± 0.14 0.75 ± 0.15 1.10 ± 0.10* P < 0.05
(ml/min/g) Control 0.68 ± 0.2 0.46 ± 0.09* 0.58 ± 0.09 0.81 ± 0.09 0.93 ± 0.20* P < 0.01
Spleen TELM 3.45 ± 0.59 0.53 ± 0.15* 3.45 ± 0.76 3.99 ± 0.67 3.49 ± 0.39 P < 0.01
(ml/min/g) Control 3.60 ± 0.26 0.77 ± 0.37* 4.44 ± 0.59 4.89 ± 0.41 3.82 ± 0.40 P < 0.001
Stomach TELM 0.29 ± 0.06 0.08 ± 0.01* 0.17 ± 0.02 0.23 ± 0.03 0.30 ± 0.04 P < 0.001
(ml/min/g) Control 0.23 ± 0.03 0.06 ± 0.01* 0.16 ± 0.02 0.20 ± 0.02 0.28 ± 0.04 P < 0.0001
Pancreas TELM 0.26 ± 0.01 0.05 ± 0.01* 0.18 ± 0.01 0.37 ± 0.04 0.55 ± 0.05* P < 0.00001
(ml/min/g) Control 0.25 ± 0.04 0.05 ± 0.01* 0.15 ± 0.02 0.31 ± 0.05 0.48 ± 0.05* P < 0.00001
Jejunum TELM 0.37 ± 0.03 0.20 ± 0.02* 0.36 ± 0.03 0.41 ± 0.04 0.55 ± 0.05* P < 0.0001
(ml/min/g) Control 0.44 ± 0.02 0.23 ± 0.02* 0.41 ± 0.04 0.42 ± 0.02 0.52 ± 0.04* P < 0.001
Colon TELM 0.40 ± 0.03 0.20 ± 0.02* 0.48 ± 0.04 0.51 ± 0.03 0.57 ± 0.03* P < 0.00001
(ml/min/g) Control 0.49 ± 0.07 0.25 ± 0.04* 0.61 ± 0.08 0.61 ± 0.07 0.57 ± 0.09* P < 0.0001
Kidney TELM 3.40 ± 0.10 2.36 ± 0.41 2.67 ± 0.21 3.85 ± 0.30 4.62 ± 0.22* P < 0.0001
(ml/min/g) Control 3.40 ± 0.21 2.50 ± 0.41 2.82 ± 0.11 3.80 ± 0.22 4.63 ± 0.16* P < 0.001
Adrenal gland TELM 1.69 ± 0.20 6.36 ± 1.56* 3.11 ± 0.81 2.01 ± 0.21 2.43 ± 0.35* P < 0.05
(ml/min/g) Control 1.70 ± 0.09 5.09 ± 0.97* 2.14 ± 0.16 2.51 ± 0.24 2.19 ± 0.22 P < 0.05
TELM = angiotensin II antagonist telmisartan; *P < 0.05 vs pre-arrest values by Wilcoxon matched pairs test.
Available online http://ccforum.com/content/2/2/49significant differences in splanchnic or non-splanchnic
organ perfusion between the two groups were found.
In response to cardiac arrest, cardiocirculatory shock or
heart failure, vasopressor hormones are endogenously
released to maintain vital organ perfusion by increasing
peripheral vascular resistance [7,18,19]. The splanchnic
hemodynamic response to circulatory shock is
characterized by a disproportionate, selective vasocon-
striction resulting in a more pronounced decrease in intes-
tinal perfusion, particularly if the shock is severe and/or
prolonged [20,21]. Catecholamines, in addition to precap-
illary splanchnic vasoconstriction, predominantly increase
systemic venous return by alpha-stimulation of post-capil-
Table 3
Hepatic plasma flow and hepatic blood flow (mean ± SEM) pre-arrest and during the post-resuscitation phase
Group Pre-arrest Post-resuscitation phase Friedmann
30 min 90 min 240 min
Hepatic plasma 
flow
TELM 0.46 ± 0.04 0.48 ± 0.05 0.51 ± 0.06 0.64 ± 0.10* P < 0.01
(l/min) Control 0.43 ± 0.06 0.45 ± 0.05 0.52 ± 0.06 0.61 ± 0.12* P < 0.01
Hepatic blood flow TELM 0.64 ± 0.06 0.66 ± 0.06 0.68 ± 0.07 0.83 ± 0.13* P < 0.05
(l/min) Control 0.60 ± 0.08 0.62 ± 0.07 0.72 ± 0.09 0.81 ± 0.16* P < 0.05
*P < 0.05 vs pre-arrest values by Wilcoxon matched pairs test.
Table 4
Arterial blood gases (mean ± SEM) pre-arrest and during the post-resuscitation phase
Group Pre-arrest Post-resuscitation phase Friedmann
5 min 30 min 90 min 240 min
pH TELM 7.47 ± 0.01 7.33 ± 0.02* 7.34 ± 0.02 7.45 ± 0.01 7.50 ± 0.01* P < 0.0001
Control 7.47 ± 0.01 7.34 ± 0.02* 7.39 ± 0.02 7.44 ± 0.01 7.49 ± 0.01 P < 0.001
PaO2 TELM 433 ± 10 424 ± 20 423 ± 24 444 ± 16 425 ± 14 ns
(mmHg) Control 434 ± 8 426 ± 15 433 ± 18 442 ± 18 439 ± 13 ns
PaCO2 TELM 37.8 ± 0.3 39.4 ± 2.4 42.7 ± 1.6 37.9 ± 0.4 38.8 ± 0.4 P < 0.05
(mmHg) Control 39.2 ± 0.9 42.6 ± 2.3 41.8 ± 1.1 39.1 ± 1.2 38.0 ± 0.6 P < 0.05
BE TELM 4.0 ± 0.5 -4.6 ± 1.0* -2.0 ± 1.1 2.4 ± 0.8 6.2 ± 0.4* P < 0.00001
Control 4.4 ± 0.3 -2.5 ± 0.4* -0.2 ± 0.8 2.6 ± 1.3 5.4 ± 0.9 P < 0.001
ns = not significant. PaO2 = arterial partial pressure of oxygen; PaCO2 = arterial partial pressure of carbon dioxide. *P < 0.05 vs pre-arrest values 
by Wilcoxon matched pairs test.
Table 5
Hepatic venous blood gases (mean ± SEM) pre-arrest and during the post-resuscitation phase
Group Pre-arrest Post-resuscitation phase Friedmann
5 min 30 min 90 min 240 min
pH hep ven TELM 7.42 ± 0.01 7.21 ± 0.02* 7.29 ± 0.02 7.40 ± 0.01 7.44 ± 0.01 P < 0.0001
Control 7.42 ± 0.01 7.24 ± 0.01* 7.31 ± 0.01 7.39 ± 0.01 7.43 ± 0.01 P < 0.001
PHVO2 TELM 37.9 ± 1.6 29.4 ± 3.2 36.3 ± 1.8 34.4 ± 3.8 33.4 ± 1.7 ns
(mmHg) Control 34.7 ± 2.8 28.2 ± 3.3 31.7 ± 2.3 31.2 ± 2.0 29.1 ± 2.9 ns
PHVCO2 TELM 45.1 ± 1.1 57.7 ± 1.7* 52.1 ± 2.4 45.7 ± 1.1 45.9 ± 0.8 P < 0.0001
(mmHg) Control 46.3 ± 1.5 58.9 ± 1.6* 54.0 ± 1.6 47.2 ± 0.8 45.8 ± 0.9 P < 0.001
BE TELM 4.5 ± 0.5 -5.3 ± 1.0* -1.8 ± 1.1 2.9 ± 1.3 6.1 ± 0.6 P < 0.0001
Control 4.9 ± 0.4 -3.1 ± 0.4* +0.1 ± 0.9 4.0 ± 1.4 5.7 ± 1.0 P < 0.001
pH hep ven = hepatic venous pH; PHVO2 = hepatic venous partial pressure of oxygen; PHVCO2 = hepatic venous partial pressure of carbon 
dioxide; BE = base excess; TELM = angiotensin II antagonist telmisartan; ns = not significant. *P < 0.05 vs pre-arrest values by Wilcoxon matched 
pairs test.Page 5 of 7
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selectively constrict intestinal and splenic resistance ves-
sels [23,24]. Angiotensin II is considered the most potent
intestinal vasoconstrictor, and the splanchnic hemody-
namic response to circulatory shock is mediated predomi-
nantly by the renin-angiotensin axis [25]. In dogs subjected
to cardiogenic shock, the degree of splanchnic vasospasm
correlated with serum ANG II concentrations, and either
surgical or pharmacological ablation of the renin-angi-
otensin system completely prevented this disproportionate
splanchnic vasoconstriction [20,21].
Results from our study demonstrate that, during the imme-
diate post-resuscitation phase in pigs, the perfusion condi-
tions in vital organs such as the brain or heart, as well as
splanchnic organs, are much more disproportionate. In par-
ticular, we found that 5 min after ROSC, in both the TELM
group and control group (TELM/control), regional organ
blood flow of the cortex, adrenal gland and left ventricular
myocardium increased to 583/597%, 376/300%, and
137/110% of pre-arrest values, respectively, whereas car-
diac index and regional organ blood flow of the liver, kidney,
jejunum, colon, stomach, pancreas and spleen decreased
to 57/56%, 80/68%, 69/74%, 54/52%, 50/51%, 28/
26%, 19/20% and 15/21% of pre-arrest values, respec-
tively. However, 90 min after ROSC, pre-arrest perfusion
values both in non-splanchnic and splanchnic organs were
achieved in both groups. At 240 min after ROSC, perfusion
of both splanchnic and non-splanchnic organs exceeded
pre-arrest values. This could be attributed to a biphasic
effect of vasopressin causing a strong initial vasoconstric-
tion, with a consecutive vasodilatation [26,27]. In particular,
no significant differences between the TELM and the con-
trol group were found with respect to the degree or speed
of recovery of organ perfusion, indicating no additional ben-
efit of ANG II antagonism with respect to organ perfusion.
In addition, total peripheral resistance and hence systemic
blood pressure are reported to be significantly affected by
changes in splanchnic vascular resistance [9]. In our study,
no significant differences in mean arterial pressure
between the two groups were found and, therefore, clini-
cally relevant changes in splanchnic vascular resistance
after TELM administration are unlikely. On the other hand,
in all of the studies in which beneficial effects of blockade
of the renin-angiotensin system on splanchnic perfusion
were found, the degree of hemorrhagic and/or cardiogenic
shock was more severe, its duration was more pronounced,
and blockade of the renin-angiotensin axis was performed
before induction of circulatory depression [20,28]. We
therefore conclude that, during the immediate post-resusci-
tation phase in pigs, splanchnic vasoconstriction must be
mainly attributed to vasopressors other than ANG II, and
that activation of the renin-angiotensin axis is not the pre-
dominant mechanism responsible for splanchnic hypoper-
fusion in this particular situation. Although we did not
measure plasma hormone levels in this study, these results
agree to some extent with what we have found in humans.
In comparison with the normal ranges of values, plasma
concentrations of catecholamines and vasopressin during
CPR were much higher than those of renin [7,18].
Ultimately, we used vasopressin during CPR because this
drug has been shown to be superior to epinephrine with
respect to cerebral/myocardial perfusion in this setting and
the percentage of successful resuscitations [3]. However,
both in normotensive and in hemorrhagic cats, the renin-
angiotensin and vasopressin systems have been reported
to be redundant mechanisms with respect to intestinal
vasoconstriction, as in the absence of one control system
the other maintains intestinal resistance [29]. In addition,
vasopressin administration in normotensive animals has
been found to inhibit renin release via direct action on jux-
taglomerular cells [30,31]. To what degree similar mecha-
nisms can be found during CPR conditions before and after
vasopressin administration is, however, open to question.
As we were not able to measure plasma levels of renin,
angiotensin and vasopressin, interactions between these
three hormones in this particular situation cannot be
excluded.
Independent of whether severe splanchnic hypoperfusion
is induced by cardiac tamponade, partial mechanical occlu-
sion or vasoconstrictor infusion, a major factor protecting
the intestinal tissue from ischemic damage is its ability to
increase oxygen extraction [32–34]. In addition, intestinal
oxygen extraction depends on the effects of vasoconstric-
tive drugs on intestinal vasculature. Alpha-receptor stimula-
tion depresses O2 extraction by closing precapillary
sphincters and thus limiting cellular oxygen supply [35].
Vasopressin, epinephrine in high doses or epinephrine after
propranolol had similar effects to norepinephrine, whereas
epinephrine in low doses increased oxygen extraction of
the small bowel, presumably by dilatating hypoperfused
capillaries [34]. At no point during our study did we observe
clinically relevant differences in global or regional intestinal
blood flow between the groups. It is therefore not surprising
that, with respect to hepatic venous PO2, we also found no
significant differences between the groups.
The relevance of this study is limited as an experimental
model with healthy animals were used. Pre-existing athero-
sclerosis, long lasting hypoxia and the need for higher vaso-
pressor doses after prolonged arrest times may cause a
more profound cardiovascular dysfunction after CPR and a
more pronounced impairment of splanchnic and non-
splanchnic organ perfusion during and after CPR. In addi-
tion, the time delay from ventricular fibrillation to restoration
of spontaneous circulation may be an important period for
the activation of the renin-angiotensin system, and,
therefore, administration of an ANG II antagonist pre-arrest
Available online http://ccforum.com/content/2/2/49or during CPR seems to be reasonable. However, impair-
ment of vasoconstriction due to blockade of the renin-angi-
otensin system could affect resuscitation success by
deteriorating coronary perfusion pressure during CPR.
We therefore conclude that during the immediate post-
resuscitation phase in pigs, regional organ perfusion is dis-
proportionate and characterized by the coincidence of
increased cerebral or myocardial blood flow and decreased
intestinal blood flow. Normalization of regional organ blood
flow occurred within 90 min after ROSC; and after admin-
istration of an ANG II antagonist, no significant differences
in splanchnic and non-splanchnic organ perfusion in com-
parison to saline were found.
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